Dosage forms and related therapies
2 Assignments
0 Petitions
Accused Products
Abstract
This invention is directed in part to novel doses, dosage formulations, and routes of administration of such doses and dose formulations, said dose and dose formulations containing one or more copper chelators, for example, one or more trientine active agents, including trientine analogues, trientine salts, trientine prodrugs, and trientine derivatives, useful in the treatment of diseases, disorders and conditions, including in indications where copper may play a role.
-
Citations
171 Claims
-
1-128. -128. (canceled)
- 129. A composition comprising a pharmaceutically acceptable carrier and an effective amount of a pharmaceutically acceptable acid addition salt of triethylenetetramine and succinic acid.
-
145. A composition comprising a pharmaceutically acceptable carrier and a pharmaceutically acceptable acid addition salt of triethylenetetramine and succinic acid in an amount selected from the group consisting of 1.2 mg, 10 mg, 12 mg, 20 mg, 30 mg, and 40 mg.
Specification